Marshall Wace Asia’s Orthofix Medical OFIX Stock Holding History

Marshall Wace Asia’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,105	Closed	-$58K	–	118
2018 Q4	$58K	Buy	+1,105	New	+$62.9K	﹤0.01%	83

Other funds holding OFIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Marshall Wace Asia's OFIX Position: Q1 2019 in Review

Marshall Wace Asia sold out of Orthofix Medical (OFIX) in Q1 2019, closing a stake of 1,105 shares — an estimated $58K sold.

Marshall Wace Asia first reported a position in OFIX in Q4 2018 and held it in 1 quarter. The position peaked at $58K in Q4 2018. 172 funds tracked by Wall St. Rank hold OFIX as of Q1 2019.

Marshall Wace Asia reported no remaining Orthofix Medical position as of Q1 2019 after selling out during the quarter.
Marshall Wace Asia sold 1,105 Orthofix Medical shares in Q1 2019, an estimated $58K.
Marshall Wace Asia first reported a position in Orthofix Medical in Q4 2018 and held it in 1 quarter.
Marshall Wace Asia's Orthofix Medical position peaked at $58K in Q4 2018.
172 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2019.

Based on Marshall Wace Asia's 13F filing for Q1 2019, filed 14 May 2019.